Application of Sophora flavescens extract in the treatment of hpv
A technology of extract and Sophora flavescens, which is applied in the field of medicine, can solve the problems of not finding drugs with curative effect and affirming HPV virus, etc., and achieve the effect of exact curative effect.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0018] Take 10 g of Sophora flavescens powder, extract according to the arrangement of orthogonal experiments in Table 1, and use the Sophora flavescens yield as an index to measure the extraction results.
[0019] Adopt ethanol reflux method to extract matrine, comprising the following steps:
[0020] (1) Using Sophora flavescens as raw material, reflux extraction with 60% ethanol by volume percentage concentration to obtain reflux liquid, the ratio of solid to liquid is 1:12; use the ethanol reflux method to extract twice, and recover ethanol by distillation under reduced pressure and obtain the extracted extract;
[0021] (2) Add 1% by weight cellulase and 1% sodium sulfite to the extract, incubate at 37±1°C for 12-24 hours, and then filter to obtain the filtrate;
[0022] (3) After adjusting the pH of the filtrate to between 3 and 4 with HCl, filter the filtrate, and adjust the pH to between 10 and 11 with NaOH, and then concentrate the filtrate;
[0023] (4) Extract the...
Embodiment 2
[0024] Embodiment 2: pharmacodynamic experiment
[0025] 1. Case data Patients who were positive for cervical HPV infection in the obstetrics and gynecology clinic of a hospital in Lanzhou from December 2012 to December 2013 were randomly divided into 3 groups according to the admission number, 120 cases in the treatment group and 120 cases in the positive control group. The negative control group excluded some patients who were not suitable for other factors, totaling 120 cases.
[0026] 2 Inclusion criteria (1) Sexual life history or married non-pregnant women, aged 18-45 years; (2) HPV-DNA infection positive; (3) Cervical intraepithelial neoplasia (CIN) grade I; (4) No major organ disease; (5) No history of drug allergy (especially those with allergic constitution); (6) The patient gave informed consent to accept this test. The exclusion criteria were: acute reproductive tract inflammation (gonorrhea, mycoplasma or chlamydia infection); those who interrupted the treatment ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com